Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.
Identifieur interne : 002409 ( PubMed/Curation ); précédent : 002408; suivant : 002410Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.
Auteurs : A-F Gabrielli [Suisse] ; A. Montresor ; L. Chitsulo ; D. Engels ; L. SavioliSource :
- Transactions of the Royal Society of Tropical Medicine and Hygiene [ 1878-3503 ] ; 2011.
Descripteurs français
- KwdFr :
- Analyse coût-bénéfice, Animaux, Antihelminthiques (usage thérapeutique), Facteurs de risque, Femelle, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Helminthiase (), Helminthiase (traitement médicamenteux), Helminthiase (épidémiologie), Humains, Mâle, Onchocercose (), Onchocercose (traitement médicamenteux), Onchocercose (épidémiologie), Santé publique, Schistosomiase (), Schistosomiase (traitement médicamenteux), Schistosomiase (épidémiologie), Sol (parasitologie), Sélection de patients.
- MESH :
- parasitologie : Sol.
- traitement médicamenteux : Filariose lymphatique, Helminthiase, Onchocercose, Schistosomiase.
- usage thérapeutique : Antihelminthiques.
- épidémiologie : Filariose lymphatique, Helminthiase, Onchocercose, Schistosomiase.
- Analyse coût-bénéfice, Animaux, Facteurs de risque, Femelle, Filariose lymphatique, Helminthiase, Humains, Mâle, Onchocercose, Santé publique, Schistosomiase, Sélection de patients.
English descriptors
- KwdEn :
- Animals, Anthelmintics (therapeutic use), Cost-Benefit Analysis, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Female, Helminthiasis (drug therapy), Helminthiasis (epidemiology), Helminthiasis (prevention & control), Humans, Male, Onchocerciasis (drug therapy), Onchocerciasis (epidemiology), Onchocerciasis (prevention & control), Patient Selection, Public Health, Risk Factors, Schistosomiasis (drug therapy), Schistosomiasis (epidemiology), Schistosomiasis (prevention & control), Soil (parasitology).
- MESH :
- chemical , parasitology : Soil.
- chemical , therapeutic use : Anthelmintics.
- drug therapy : Elephantiasis, Filarial, Helminthiasis, Onchocerciasis, Schistosomiasis.
- epidemiology : Elephantiasis, Filarial, Helminthiasis, Onchocerciasis, Schistosomiasis.
- prevention & control : Elephantiasis, Filarial, Helminthiasis, Onchocerciasis, Schistosomiasis.
- Animals, Cost-Benefit Analysis, Female, Humans, Male, Patient Selection, Public Health, Risk Factors.
Abstract
Preventive chemotherapy (PC), the large-scale distribution of anthelminthic drugs to population groups at risk, is the core intervention recommended by the WHO for reducing morbidity and transmission of the four main helminth infections, namely lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The strategy is widely implemented worldwide but its general theoretical foundations have not been described so far in a comprehensive and cohesive manner. Starting from the information available on the biological and epidemiological characteristics of helminth infections, as well as from the experience generated by disease control and elimination interventions across the world, we extrapolate the fundamentals and synthesise the principles that regulate PC and justify its implementation as a sound and essential public health intervention. The outline of the theoretical aspects of PC contributes to a thorough understanding of the different facets of this strategy and helps comprehend opportunities and limits of control and elimination interventions directed against helminth infections.
DOI: 10.1016/j.trstmh.2011.08.013
PubMed: 22040463
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002409
Links to Exploration step
pubmed:22040463Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.</title><author><name sortKey="Gabrielli, A F" sort="Gabrielli, A F" uniqKey="Gabrielli A" first="A-F" last="Gabrielli">A-F Gabrielli</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases (NTD), World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Montresor, A" sort="Montresor, A" uniqKey="Montresor A" first="A" last="Montresor">A. Montresor</name></author><author><name sortKey="Chitsulo, L" sort="Chitsulo, L" uniqKey="Chitsulo L" first="L" last="Chitsulo">L. Chitsulo</name></author><author><name sortKey="Engels, D" sort="Engels, D" uniqKey="Engels D" first="D" last="Engels">D. Engels</name></author><author><name sortKey="Savioli, L" sort="Savioli, L" uniqKey="Savioli L" first="L" last="Savioli">L. Savioli</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:22040463</idno><idno type="pmid">22040463</idno><idno type="doi">10.1016/j.trstmh.2011.08.013</idno><idno type="wicri:Area/PubMed/Corpus">002409</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002409</idno><idno type="wicri:Area/PubMed/Curation">002409</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002409</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.</title><author><name sortKey="Gabrielli, A F" sort="Gabrielli, A F" uniqKey="Gabrielli A" first="A-F" last="Gabrielli">A-F Gabrielli</name><affiliation wicri:level="1"><nlm:affiliation>Department of Control of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Control of Neglected Tropical Diseases (NTD), World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Montresor, A" sort="Montresor, A" uniqKey="Montresor A" first="A" last="Montresor">A. Montresor</name></author><author><name sortKey="Chitsulo, L" sort="Chitsulo, L" uniqKey="Chitsulo L" first="L" last="Chitsulo">L. Chitsulo</name></author><author><name sortKey="Engels, D" sort="Engels, D" uniqKey="Engels D" first="D" last="Engels">D. Engels</name></author><author><name sortKey="Savioli, L" sort="Savioli, L" uniqKey="Savioli L" first="L" last="Savioli">L. Savioli</name></author></analytic><series><title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title><idno type="eISSN">1878-3503</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Anthelmintics (therapeutic use)</term><term>Cost-Benefit Analysis</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Female</term><term>Helminthiasis (drug therapy)</term><term>Helminthiasis (epidemiology)</term><term>Helminthiasis (prevention & control)</term><term>Humans</term><term>Male</term><term>Onchocerciasis (drug therapy)</term><term>Onchocerciasis (epidemiology)</term><term>Onchocerciasis (prevention & control)</term><term>Patient Selection</term><term>Public Health</term><term>Risk Factors</term><term>Schistosomiasis (drug therapy)</term><term>Schistosomiasis (epidemiology)</term><term>Schistosomiasis (prevention & control)</term><term>Soil (parasitology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Animaux</term><term>Antihelminthiques (usage thérapeutique)</term><term>Facteurs de risque</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Helminthiase ()</term><term>Helminthiase (traitement médicamenteux)</term><term>Helminthiase (épidémiologie)</term><term>Humains</term><term>Mâle</term><term>Onchocercose ()</term><term>Onchocercose (traitement médicamenteux)</term><term>Onchocercose (épidémiologie)</term><term>Santé publique</term><term>Schistosomiase ()</term><term>Schistosomiase (traitement médicamenteux)</term><term>Schistosomiase (épidémiologie)</term><term>Sol (parasitologie)</term><term>Sélection de patients</term></keywords><keywords scheme="MESH" type="chemical" qualifier="parasitology" xml:lang="en"><term>Soil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anthelmintics</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Onchocerciasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Onchocerciasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Sol</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Onchocerciasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term><term>Helminthiase</term><term>Onchocercose</term><term>Schistosomiase</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihelminthiques</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Helminthiase</term><term>Onchocercose</term><term>Schistosomiase</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cost-Benefit Analysis</term><term>Female</term><term>Humans</term><term>Male</term><term>Patient Selection</term><term>Public Health</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Animaux</term><term>Facteurs de risque</term><term>Femelle</term><term>Filariose lymphatique</term><term>Helminthiase</term><term>Humains</term><term>Mâle</term><term>Onchocercose</term><term>Santé publique</term><term>Schistosomiase</term><term>Sélection de patients</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Preventive chemotherapy (PC), the large-scale distribution of anthelminthic drugs to population groups at risk, is the core intervention recommended by the WHO for reducing morbidity and transmission of the four main helminth infections, namely lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The strategy is widely implemented worldwide but its general theoretical foundations have not been described so far in a comprehensive and cohesive manner. Starting from the information available on the biological and epidemiological characteristics of helminth infections, as well as from the experience generated by disease control and elimination interventions across the world, we extrapolate the fundamentals and synthesise the principles that regulate PC and justify its implementation as a sound and essential public health intervention. The outline of the theoretical aspects of PC contributes to a thorough understanding of the different facets of this strategy and helps comprehend opportunities and limits of control and elimination interventions directed against helminth infections.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22040463</PMID><DateCreated><Year>2011</Year><Month>11</Month><Day>14</Day></DateCreated><DateCompleted><Year>2012</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3503</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>12</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Transactions of the Royal Society of Tropical Medicine and Hygiene</Title><ISOAbbreviation>Trans. R. Soc. Trop. Med. Hyg.</ISOAbbreviation></Journal><ArticleTitle>Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.</ArticleTitle><Pagination><MedlinePgn>683-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trstmh.2011.08.013</ELocationID><Abstract><AbstractText>Preventive chemotherapy (PC), the large-scale distribution of anthelminthic drugs to population groups at risk, is the core intervention recommended by the WHO for reducing morbidity and transmission of the four main helminth infections, namely lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The strategy is widely implemented worldwide but its general theoretical foundations have not been described so far in a comprehensive and cohesive manner. Starting from the information available on the biological and epidemiological characteristics of helminth infections, as well as from the experience generated by disease control and elimination interventions across the world, we extrapolate the fundamentals and synthesise the principles that regulate PC and justify its implementation as a sound and essential public health intervention. The outline of the theoretical aspects of PC contributes to a thorough understanding of the different facets of this strategy and helps comprehend opportunities and limits of control and elimination interventions directed against helminth infections.</AbstractText><CopyrightInformation>Copyright © 2011 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gabrielli</LastName><ForeName>A-F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Control of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montresor</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chitsulo</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Engels</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Savioli</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trans R Soc Trop Med Hyg</MedlineTA><NlmUniqueID>7506129</NlmUniqueID><ISSNLinking>0035-9203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012987">Soil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Trans R Soc Trop Med Hyg. 2012 May;106(5):327-8</RefSource><PMID Version="1">22445081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Investig Drugs. 2005 Dec;14(12):1513-26</RefSource><PMID Version="1">16307491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World Health Organ Tech Rep Ser. 1995;852:1-104</RefSource><PMID Version="1">7541171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Pharmacother. 2005 Feb;6(2):179-200</RefSource><PMID Version="1">15757416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2009 Sep;5(9):e1000571</RefSource><PMID Version="1">19730700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2009 May 13;338:b1686</RefSource><PMID Version="1">19439451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1998;76 Suppl 2:22-5</RefSource><PMID Version="1">10063669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull Pan Am Health Organ. 1993;27(4):397-403</RefSource><PMID Version="1">8312963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Aug;77(2):334-41</RefSource><PMID Version="1">17690408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2004 Aug;20(8):347-51</RefSource><PMID Version="1">15246314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008 Mar 26;2(3):e126</RefSource><PMID Version="1">18365031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2002 May;82(2):157-68</RefSource><PMID Version="1">12020888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Sep 23;368(9541):1106-18</RefSource><PMID Version="1">16997665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2007 Jan;101(1):34-9</RefSource><PMID Version="1">17028047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 Jul;75(1):83-92</RefSource><PMID Version="1">16837713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008 Apr 30;2(4):e230</RefSource><PMID Version="1">18446206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 1996 Nov;55(5):477-81</RefSource><PMID Version="1">8940976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:395-441</RefSource><PMID Version="1">16735170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:311-48</RefSource><PMID Version="1">16735168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1999;77(4):300</RefSource><PMID Version="1">10327707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2003 Dec;19(12):547-51</RefSource><PMID Version="1">14642761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2006 Mar 28;5:5</RefSource><PMID Version="1">16569234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009 Jul 21;3(7):e497</RefSource><PMID Version="1">19621091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2008 Oct;86(10):780-7, A</RefSource><PMID Version="1">18949215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 May 6;367(9521):1521-32</RefSource><PMID Version="1">16679166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Public Health. 1981;2:101-5</RefSource><PMID Version="1">6890842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2009;68:247-61</RefSource><PMID Version="1">19289197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1965 Sep;59(5):489-506</RefSource><PMID Version="1">5860312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Biol Sci. 2006 Nov 7;273(1602):2743-8</RefSource><PMID Version="1">17015324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2003 Jun;87(1):103-9</RefSource><PMID Version="1">12781384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2005 Oct;19(10):1057-66</RefSource><PMID Version="1">16304585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1992 May 23;339(8804):1253-7</RefSource><PMID Version="1">1349668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:349-94</RefSource><PMID Version="1">16735169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2007 Aug 31;82(35):314-6</RefSource><PMID Version="1">17763565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:567-622</RefSource><PMID Version="1">16735173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1997;75(6):491-503</RefSource><PMID Version="1">9509621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010 Nov 23;4(11):e897</RefSource><PMID Version="1">21124888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Leiden. 1990;59(1-2):177-91</RefSource><PMID Version="1">2198750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Helminthol. 2005 Sep;79(3):207-16</RefSource><PMID Version="1">16153314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2007 Sep 6;357(10):1018-27</RefSource><PMID Version="1">17804846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2007 Aug;101(8):759-65</RefSource><PMID Version="1">17568642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2005 Aug;99(8):599-609</RefSource><PMID Version="1">15935413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitol Int. 2006;55 Suppl:S105-9</RefSource><PMID Version="1">16356763</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006373" MajorTopicYN="N">Helminthiasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009855" MajorTopicYN="N">Onchocerciasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012552" MajorTopicYN="N">Schistosomiasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012987" MajorTopicYN="N">Soil</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>06</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22040463</ArticleId><ArticleId IdType="pii">S0035-9203(11)00184-2</ArticleId><ArticleId IdType="doi">10.1016/j.trstmh.2011.08.013</ArticleId><ArticleId IdType="pmc">PMC5576527</ArticleId><ArticleId IdType="mid">EMS73835</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002409 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002409 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:22040463
|texte= Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:22040463" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |